A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/2001
12/04/2001	US6326197 Platelet suspensions and methods for resuspending platelets
12/04/2001	US6326195 Recombinant retroviral vector
12/04/2001	US6325998 Methods of treating disease using recombinant adeno-associated virus virions administered to muscle
12/04/2001	CA2218452C Novel ligands of the neuropeptide receptor hfgan72
12/04/2001	CA2049873C Anticoagulant combination of laci and sulfated polysaccharides
12/04/2001	CA2027635C Erythropoietin isoforms
11/2001
11/30/2001	CA2348847A1 New isoxazole-sulfonamide endothelin antagonists
11/29/2001	WO2001090359A2 G-protein coupled receptors
11/29/2001	WO2001090334A2 Drug metabolizing enzymes
11/29/2001	WO2001090316A2 Human circulating dendritic cell compositions and methods
11/29/2001	WO2001090156A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	WO2001090155A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/29/2001	WO2001090148A2 Neurotransmitter transporters
11/29/2001	WO2001090104A2 -(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
11/29/2001	WO2001090103A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	WO2001090100A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	WO2001090086A1 A polymorph of 5-(4-aminosulfonyl-3-fluorophenyl)-4-cyclohexyl-2-methyloxazole
11/29/2001	WO2001090076A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	WO2001090074A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a)
11/29/2001	WO2001090070A2 Caspase inhibitors and uses thereof
11/29/2001	WO2001090068A2 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	WO2001090063A2 Prodrug of an ice inhibitor
11/29/2001	WO2001090051A1 Phenylglycine derivatives
11/29/2001	WO2001090047A1 Novel mmp-2/mmp-9 inhibitors
11/29/2001	WO2001089569A1 Combinations of enzyme inhibitor-containing preparations and the use thereof
11/29/2001	WO2001089564A2 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
11/29/2001	WO2001089558A2 Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
11/29/2001	WO2001089552A1 Modulaton of alpha-6 integrin-mediated responses
11/29/2001	WO2001089542A2 Composition for improving the cell protection comprising a lipophilic antioxidant and a hydrophilic antioxidant
11/29/2001	WO2001089538A2 Apoptotic entities for use in treatment of endothelium dysfunction disorders
11/29/2001	WO2001089481A1 Prolonged release microspheres for injection delivery and preparation method
11/29/2001	WO2001089478A1 Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof
11/29/2001	WO2001089457A2 Thrombopoietin mimetics
11/29/2001	WO2001089451A2 Protease inhibitors
11/29/2001	WO2001070695A8 Pyridine derivatives as inhibitors of p38
11/29/2001	WO2001058935A3 FACTOR VII OR VIIa-LIKE MOLECULES
11/29/2001	WO2001055115A8 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/29/2001	WO2001049305A3 Process for obtaining thylakoids from plants, pure thylakoids and use thereof
11/29/2001	WO2001044465A3 Therapeutically useful synthetic oligonucleotides
11/29/2001	WO2001042471A8 Polypeptides and polynucleotides encoding same
11/29/2001	WO2001030780A3 Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
11/29/2001	WO2001027304A3 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
11/29/2001	WO2001025433A3 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization
11/29/2001	WO2001019776A3 Novel derivatives of dicarboxylic acid having pharmaceutical properties
11/29/2001	WO2000055159A3 Substituted aza-oxindole derivatives
11/29/2001	WO2000034258A3 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
11/29/2001	US20010047019 3-Aminopyrazole inhibitors of cyclin dependent kinases
11/29/2001	US20010046993 5-memberd heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists
11/29/2001	US20010046981 N-acyl-heterocycle-carboxyamides that are N-substituted with amidino-substituted rings; competitive inhibitors of thrombin; anticoagulants
11/29/2001	US20010046958 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors
11/29/2001	US20010046697 Bacillus natto culture extract
11/29/2001	US20010046495 Use of cross-linked, covalently bound urokinase plasminogen activator (scuPAR)-urokinase plasminogen activator receptor (suPAR) complex as a fibrinolytic agent
11/29/2001	US20010046490 Cell surface molecule-induced macrophage activation
11/29/2001	DE10025949A1 Arzneimittel zur Bekämpfung von Atemdepression Medications to fight respiratory depression
11/29/2001	DE10025728A1 Neue Carbamate und Harnstoffe, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten New carbamates and ureas, their preparation and use as endothelin receptor antagonists
11/29/2001	CA2429199A1 Drug metabolizing enzymes
11/29/2001	CA2410593A1 Novel mmp-2/mmp-9 inhibitors
11/29/2001	CA2410567A1 Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
11/29/2001	CA2410294A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	CA2410219A1 Prolonged release microspheres for injection delivery and preparation method
11/29/2001	CA2410096A1 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	CA2409868A1 Modulaton of alpha-6 integrin-mediated responses
11/29/2001	CA2409688A1 Method for improving the cell protection
11/29/2001	CA2409430A1 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	CA2409367A1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/29/2001	CA2408883A1 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
11/29/2001	CA2408739A1 Novel proteins and nucleic acids encoding same, diagnostic and therapeutic uses
11/29/2001	CA2408727A1 Benzophenones as inhibitors of il-1.beta. and tnf-.alpha.
11/29/2001	CA2408709A1 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	CA2408141A1 Neurotransmitter transporters
11/29/2001	CA2408140A1 G-protein coupled receptors
11/29/2001	CA2407780A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	CA2406829A1 Protease inhibitors
11/29/2001	CA2403574A1 Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof
11/29/2001	CA2380935A1 Caspase inhibitors and uses thereof
11/28/2001	EP1157987A1 S-nitrosothiols as agents for the treatment of circulatory dysfunctions
11/28/2001	EP1157705A2 Use of a phosphodiesterase inhibitor in the manufacture of a medicament for blood pressure stabilization during hemodialysis
11/28/2001	EP1157698A2 Treatment of inflammatory diseases with oxypurine nucleosides
11/28/2001	EP1157697A1 Remedies for hyperammonemia
11/28/2001	EP1157040A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
11/28/2001	EP1157024A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
11/28/2001	EP1157021A1 Sulfamato hydroxamic acid metalloprotease inhibitor
11/28/2001	EP1157010A1 Pyrazole-3-on-derivative as factor xa inhibitors
11/28/2001	EP1156804A1 Thrombopoietin mimetics
11/28/2001	EP1156803A1 LACTAM INHIBITORS OF FXa AND METHOD
11/28/2001	EP1156765A1 Hemostatic polymer useful for rapid blood coagulation and hemostasis
11/28/2001	EP0804469B1 T-cell affecting peptides
11/28/2001	EP0698108B1 Adenoviral vectors of animal origin and use thereof in gene therapy
11/28/2001	CN1324403A PRV-1 gene and the use thereof
11/28/2001	CN1324358A Imidazo [4,5-C-] pyridine-4-one derivatives with factor XA inhibiting effect
11/28/2001	CN1323583A Medicinal use of beta-ecdysterone
11/28/2001	CN1323582A Prepn. of injecta powder containing tannic acid component
11/28/2001	CN1075374C Heme antianemia medicine and preparation method
11/27/2001	US6323326 Method of solubilizing, purifying, and refolding protein
11/27/2001	US6323199 Aromatic heterocyclic hydroxy amines or amides for treatment of inflammation
11/27/2001	US6323182 Concentrate for use in preparation of dialysis solution comprising gluconic acid and glucose in amounts such that upon dilution with aqueous solution in ratio of at least about 1:150, specified concentrations are obtained
11/27/2001	US6323175 Composition comprising physiologically compatible liposome, hemoglobin encapsulated in liposome, and nitroxide encapsulated in liposome
11/27/2001	CA2184551C Iron dextran formulations
11/27/2001	CA2083286C Recombinant fibrinogenases, preparation and use thereof
11/27/2001	CA2021912C Erythropoietin (epo) peptides and antibodies directed against these

1 ... 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 ... 671